论文部分内容阅读
目的通过与经尿道2μm激光前列腺剜除术相比较,评估经尿道2μm激光前列腺剥离术治疗前列腺增生的疗效和安全性。方法随机采用经尿道2μm激光前列腺剥离术或经尿道2μm激光前列腺剜除术治疗168例前列腺增生患者,比较两种手术方式的相关临床指标。结果术前两组患者一般情况比较差异无统计学意义(P>0.05)。剥离术组切除前列腺(19.96±13.57)g,剜除术组切除前列腺(17.04±11.8)g;剥离术组的手术时间(100.7±27.8)min略大于剜除术组(97.89±40.3)min(P=0.101);剥离术组的术中出血量(10.8±7.42)ml小于剜除术组(22.73±10.9)ml,两组间比较差异有统计学意义(P<0.05);国际前列腺症状评分、生活质量评分及最大尿流率术后均有明显改善(P<0.01)。结论经尿道2μm激光前列腺剥离术与经尿道2μm激光前列腺剜除术相比,有相同的近期疗效,具有良好的止血效果,而且操作较容易,更利于推广实施,能显著降低手术风险,是治疗前列腺增生的一种新的安全、有效的微创手术方式。
Objective To evaluate the efficacy and safety of transurethral 2 μm laser prostatic ablation in the treatment of benign prostatic hyperplasia (BPH) compared with transurethral 2 μm laser prostatectomy. Methods A total of 168 patients with benign prostatic hyperplasia (BPH) were treated with transurethral 2μm laser prostatic extirpation or transurethral 2μm laser prostatectomy. The clinical parameters of the two methods were compared. Results There was no significant difference in the general situation between the two groups before operation (P> 0.05). Prostate (19.96 ± 13.57) g was removed in the dissection group and 17.04 ± 11.8 g in the removal group (100.7 ± 27.8) min, which was slightly larger than that in the resection group (97.89 ± 40.3) min P = 0.101). The mean intraoperative blood loss (10.8 ± 7.42) ml in the dissection group was less than that in the operation group (22.73 ± 10.9) ml, the difference was statistically significant (P <0.05). The International Prostate Symptom Score , Quality of life score and the maximum urinary flow rate were significantly improved (P <0.01). Conclusions Transurethral 2 μm laser prostatectomy has the same immediate curative effect compared with 2 μm laser transurethral resection of the prostate, and has good hemostatic effects. Moreover, it is easier to operate and more conducive to promotion and implementation. It can significantly reduce the surgical risk and is a good choice for treatment A new safe and effective method of minimally invasive surgery for benign prostatic hyperplasia.